The region is also expected to witness significant growth over the next few years, due to the growing number of pharma companies in the Contract Research Organization region and robust investments in R&D activities.
North America held a market share of over 7% in 2018, and is expected to increase this share in coming years. This is attributed to the focus on chronic diseases and the growing elderly population with chronic diseases in the region.
The infectious diseases segment is expected to experience 6.5% growth during the forecast period. As the prevalence of viral Contract Research Organization and bacterial infections increases, industry players are investing more in R&D to combat these problems.
Bioinformatics and novel analytical technologies are also being leveraged by these industry players to develop better treatment options. Another trend that is anticipated to impact the Contract Research Organizations market is the rapid advancement of clinical research on the Hepatitis C virus.
This is expected to spur the development of new drugs and treatments for this virus.
Comentarios